| Molecular formula | C46H56N12O6 |
| Molecular weight | 873 g/mol |
| Registered trials | 0 |
| PubChem CID | 4345065 |
What GHRP-6 Is
GHRP-6 is a synthetic peptide with the molecular formula C46H56N12O6 and a molecular weight of about 873 g/mol (PubChem CID 4345065). It has no FDA-approved label, no approved brand name, and no sanctioned medical use in humans. Any use outside of registered research settings falls outside its current regulatory status.
Regulatory Status
GHRP-6 is classified as unapproved and intended for research purposes only. No drug label, indication, or mechanism-of-action statement has been approved by regulators for this compound. No dosing or administration guidance exists in any approved reference for it.
Clinical Trial Footprint
Public trial registries currently list no registered clinical trials for GHRP-6. This means there is no available data from human studies on safety, efficacy, or outcomes to summarize at this time.
FAQ
No. GHRP-6 has no FDA-approved label, indication, or brand name. It is classified as unapproved and used only in research settings.
GHRP-6 is a synthetic peptide with the molecular formula C46H56N12O6 and a molecular weight of approximately 873 g/mol. It is cataloged in PubChem under CID 4345065.
Current public trial registries show zero registered clinical trials for GHRP-6. As a result, there is no clinical trial evidence available to summarize regarding its effects in humans.
No adverse event reports are currently available for GHRP-6 in the datasets reviewed. This reflects a lack of reported data rather than a confirmation of safety.
No. GHRP-6 has no approved medical use and no approved label describing safe or effective use in humans. It remains classified strictly as a research compound.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 4345065
Updated 2026-08-03